Clinical Trial Update: ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1

View source ↗

Summary

The ATLAS-1 study from Salma Health is currently recruiting to longitudinally assess treatment for depressed mood.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorders

Snippet

Sponsor: Salma Health, Inc. | Conditions: Depressed Mood | Status: RECRUITING